Quick Q for my clarification [Design Issues]

posted by martin  – Austria, 2012-11-06 13:29 (4979 d 02:03 ago) – Posting: # 9510
Views: 6,829

Hi ElMaestro!

Thank you for your quick reply with my attempt to answer the questions:

I was told that this design is standard for this kind of studies (one test and 2 references) and I think that straightforward doubling the sequence was intuitive with the aim to decrease the number of subjects (no power calculations available)

No idea regarding the intra-subject variability but this information may be important for planning upcoming studies

Scaling would be definitely an option if it turns out that the CV>30% (it's a NON-GXP study)

hope this helps

Martin

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
127 visitors (0 registered, 127 guests [including 16 identified bots]).
Forum time: 16:33 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5